Cargando…

An experimental design framework for Markovian gene regulatory networks under stationary control policy

BACKGROUND: A fundamental problem for translational genomics is to find optimal therapies based on gene regulatory intervention. Dynamic intervention involves a control policy that optimally reduces a cost function based on phenotype by externally altering the state of the network over time. When a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehghannasiri, Roozbeh, Shahrokh Esfahani, Mohammad, Dougherty, Edward R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302376/
https://www.ncbi.nlm.nih.gov/pubmed/30577732
http://dx.doi.org/10.1186/s12918-018-0649-8
_version_ 1783381964426838016
author Dehghannasiri, Roozbeh
Shahrokh Esfahani, Mohammad
Dougherty, Edward R.
author_facet Dehghannasiri, Roozbeh
Shahrokh Esfahani, Mohammad
Dougherty, Edward R.
author_sort Dehghannasiri, Roozbeh
collection PubMed
description BACKGROUND: A fundamental problem for translational genomics is to find optimal therapies based on gene regulatory intervention. Dynamic intervention involves a control policy that optimally reduces a cost function based on phenotype by externally altering the state of the network over time. When a gene regulatory network (GRN) model is fully known, the problem is addressed using classical dynamic programming based on the Markov chain associated with the network. When the network is uncertain, a Bayesian framework can be applied, where policy optimality is with respect to both the dynamical objective and the uncertainty, as characterized by a prior distribution. In the presence of uncertainty, it is of great practical interest to develop an experimental design strategy and thereby select experiments that optimally reduce a measure of uncertainty. RESULTS: In this paper, we employ mean objective cost of uncertainty (MOCU), which quantifies uncertainty based on the degree to which uncertainty degrades the operational objective, that being the cost owing to undesirable phenotypes. We assume that a number of conditional probabilities characterizing regulatory relationships among genes are unknown in the Markovian GRN. In sum, there is a prior distribution which can be updated to a posterior distribution by observing a regulatory trajectory, and an optimal control policy, known as an “intrinsically Bayesian robust” (IBR) policy. To obtain a better IBR policy, we select an experiment that minimizes the MOCU remaining after applying its output to the network. At this point, we can either stop and find the resulting IBR policy or proceed to determine more unknown conditional probabilities via regulatory observation and find the IBR policy from the resulting posterior distribution. For sequential experimental design this entire process is iterated. Owing to the computational complexity of experimental design, which requires computation of many potential IBR policies, we implement an approximate method utilizing mean first passage times (MFPTs) – but only in experimental design, the final policy being an IBR policy. CONCLUSIONS: Comprehensive performance analysis based on extensive simulations on synthetic and real GRNs demonstrate the efficacy of the proposed method, including the accuracy and computational advantage of the approximate MFPT-based design.
format Online
Article
Text
id pubmed-6302376
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63023762018-12-31 An experimental design framework for Markovian gene regulatory networks under stationary control policy Dehghannasiri, Roozbeh Shahrokh Esfahani, Mohammad Dougherty, Edward R. BMC Syst Biol Research BACKGROUND: A fundamental problem for translational genomics is to find optimal therapies based on gene regulatory intervention. Dynamic intervention involves a control policy that optimally reduces a cost function based on phenotype by externally altering the state of the network over time. When a gene regulatory network (GRN) model is fully known, the problem is addressed using classical dynamic programming based on the Markov chain associated with the network. When the network is uncertain, a Bayesian framework can be applied, where policy optimality is with respect to both the dynamical objective and the uncertainty, as characterized by a prior distribution. In the presence of uncertainty, it is of great practical interest to develop an experimental design strategy and thereby select experiments that optimally reduce a measure of uncertainty. RESULTS: In this paper, we employ mean objective cost of uncertainty (MOCU), which quantifies uncertainty based on the degree to which uncertainty degrades the operational objective, that being the cost owing to undesirable phenotypes. We assume that a number of conditional probabilities characterizing regulatory relationships among genes are unknown in the Markovian GRN. In sum, there is a prior distribution which can be updated to a posterior distribution by observing a regulatory trajectory, and an optimal control policy, known as an “intrinsically Bayesian robust” (IBR) policy. To obtain a better IBR policy, we select an experiment that minimizes the MOCU remaining after applying its output to the network. At this point, we can either stop and find the resulting IBR policy or proceed to determine more unknown conditional probabilities via regulatory observation and find the IBR policy from the resulting posterior distribution. For sequential experimental design this entire process is iterated. Owing to the computational complexity of experimental design, which requires computation of many potential IBR policies, we implement an approximate method utilizing mean first passage times (MFPTs) – but only in experimental design, the final policy being an IBR policy. CONCLUSIONS: Comprehensive performance analysis based on extensive simulations on synthetic and real GRNs demonstrate the efficacy of the proposed method, including the accuracy and computational advantage of the approximate MFPT-based design. BioMed Central 2018-12-21 /pmc/articles/PMC6302376/ /pubmed/30577732 http://dx.doi.org/10.1186/s12918-018-0649-8 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Dehghannasiri, Roozbeh
Shahrokh Esfahani, Mohammad
Dougherty, Edward R.
An experimental design framework for Markovian gene regulatory networks under stationary control policy
title An experimental design framework for Markovian gene regulatory networks under stationary control policy
title_full An experimental design framework for Markovian gene regulatory networks under stationary control policy
title_fullStr An experimental design framework for Markovian gene regulatory networks under stationary control policy
title_full_unstemmed An experimental design framework for Markovian gene regulatory networks under stationary control policy
title_short An experimental design framework for Markovian gene regulatory networks under stationary control policy
title_sort experimental design framework for markovian gene regulatory networks under stationary control policy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302376/
https://www.ncbi.nlm.nih.gov/pubmed/30577732
http://dx.doi.org/10.1186/s12918-018-0649-8
work_keys_str_mv AT dehghannasiriroozbeh anexperimentaldesignframeworkformarkoviangeneregulatorynetworksunderstationarycontrolpolicy
AT shahrokhesfahanimohammad anexperimentaldesignframeworkformarkoviangeneregulatorynetworksunderstationarycontrolpolicy
AT doughertyedwardr anexperimentaldesignframeworkformarkoviangeneregulatorynetworksunderstationarycontrolpolicy
AT dehghannasiriroozbeh experimentaldesignframeworkformarkoviangeneregulatorynetworksunderstationarycontrolpolicy
AT shahrokhesfahanimohammad experimentaldesignframeworkformarkoviangeneregulatorynetworksunderstationarycontrolpolicy
AT doughertyedwardr experimentaldesignframeworkformarkoviangeneregulatorynetworksunderstationarycontrolpolicy